Denise C. Connolly

Women's Cancer Program, Fox Chase Cancer Center

Research Area

Biography

Denise C. Connolly has not added Biography.
If you are Denise C. Connolly and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 18	2010

Other Publications

Article	Year
Activation of cancer-specific gene expression by the survivin promoter. Journal of the National Cancer Institute\| PubMed ID: 11929953	2002
Female mice chimeric for expression of the simian virus 40 TAg under control of the MISIIR promoter develop epithelial ovarian cancer. Cancer research\| PubMed ID: 12649204	2003
Focus on epithelial ovarian cancer. Cancer cell\| PubMed ID: 14749123	2004
Membrane localization of v-ErbB is required but not sufficient for ligand-independent transformation. Experimental cell research\| PubMed ID: 15149858	2004
Pathology of Ovarian Neoplasms in Genetically Modified Mice. Comparative medicine\| PubMed ID: 15382342	2004
Cyclooxygenase-1 is overexpressed in multiple genetically engineered mouse models of epithelial ovarian cancer. Cancer research\| PubMed ID: 16510568	2006
Recombinant human Mullerian inhibiting substance inhibits long-term growth of MIS type II receptor-directed transgenic mouse ovarian cancers in vivo. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 16533786	2006
Mullerian Inhibiting Substance enhances subclinical doses of chemotherapeutic agents to inhibit human and mouse ovarian cancer. Proceedings of the National Academy of Sciences of the United States of America\| PubMed ID: 17088539	2006
RAD001 (Everolimus) delays tumor onset and progression in a transgenic mouse model of ovarian cancer. Cancer research\| PubMed ID: 17363557	2007
Magnetic resonance imaging for detection and determination of tumor volume in a genetically engineered mouse model of ovarian cancer. Cancer biology & therapy\| PubMed ID: 17986851	2007
Expression of activated PIK3CA in ovarian surface epithelium results in hyperplasia but not tumor formation. PloS one\| PubMed ID: 19172191	2009
NEDD9 promotes oncogenic signaling in mammary tumor development. Cancer research\| PubMed ID: 19738060	2009
Animal models of ovarian cancer. Cancer treatment and research\| PubMed ID: 19763445	2009
Induction of ovarian leiomyosarcomas in mice by conditional inactivation of Brca1 and p53. PloS one\| PubMed ID: 20046879	2009
Distinct expression levels and patterns of stem cell marker, aldehyde dehydrogenase isoform 1 (ALDH1), in human epithelial cancers. PloS one\| PubMed ID: 20422001	2010
Strategies for high-resolution imaging of epithelial ovarian cancer by laparoscopic nonlinear microscopy. Translational oncology\| PubMed ID: 20563260	2010
Xenograft and Transgenic Mouse Models of Epithelial Ovarian Cancer and Non Invasive Imaging Modalities to Monitor Ovarian Tumor Growth In situ -Applications in Evaluating Novel Therapeutic A... Current protocols in pharmacology / editorial board, S.J. Enna (editor-in-chief) ... [et al.]\| PubMed ID: 20634901	2009
Development of a syngeneic mouse model of epithelial ovarian cancer. Journal of ovarian research\| PubMed ID: 20958993	2010
Miscommunication involving 'standard care'. Response to protocol review scenario: specify all medications. Lab animal\| PubMed ID: 21326182	2011
Xenograft and transgenic mouse models of epithelial ovarian cancer and non-invasive imaging modalities to monitor ovarian tumor growth in situ: applications in evaluating novel therapeutic a... Current protocols in pharmacology / editorial board, S.J. Enna (editor-in-chief) ... [et al.]\| PubMed ID: 22294392	2009